Virtual Immersive Communication Training on Recommending Immunizations
NCT04368455 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 161
Last updated 2023-04-12
Summary
Our approach will be to implement Virtual Immersive Communication Training on Recommending Immunizations (VICTORI), an intervention that includes a self-directed app based curriculum and VR simulations, designed to increase the strength and consistency of HPV vaccine recommendations among clinicians. A single-site intervention assessing the efficacy of VICTORI in increasing HPV vaccine rates will be conducted.
Conditions
Interventions
- BEHAVIORAL
-
Virtual Immersive Communication Training on Recommending Immunizations (VICTORI)
An intervention that includes a self-directed app based curriculum and virtual reality simulations, designed to increase the strength and consistency of HPV vaccine recommendations among clinicians.
- BEHAVIORAL
-
HPV Same Way Same Day App
An intervention that includes a self-directed app based curriculum
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Brittany Rosen
lead OTHER
Principal Investigators
-
F. Joseph Real, MD, MEd · Children's Hospital Medical Center, Cincinnati
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-06-23
- Primary Completion
- 2021-03-31
- Completion
- 2022-12-01
Countries
- United States
Study Locations
More Related Trials
-
Therapeutic Vaccine in Patients With Human Papillomavirus HPV-positive Oropharyngeal Cancer
NCT06007092 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Text and Talk: A Multi-level Intervention to Increase Provider HPV Vaccine Recommendation Effectiveness
NCT05006833 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treating HPV
NCT06959563 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults
NCT00798265 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer
NCT06319963 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Engaging Patients and Providers in Collaborative Communication on HPV Vaccination (EPICC-HPV)
NCT03267251 ·Status: WITHDRAWN ·Phase: NA
-
Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection
NCT00513526 ·Status: COMPLETED ·Phase: PHASE2
-
PREVENT Pilot HPV - Related Cancers Trial
NCT06738355 ·Status: COMPLETED ·Phase: NA
-
Electronic Messaging to Increase Human Papillomavirus Vaccine Utilization and Adherence Among College Students
NCT01568515 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old
NCT05056402 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
NCT03813940 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus (HPV) Vaccine With Other Vaccines in Healthy Female Subjects
NCT00426361 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Feasibility of TA-CIN Vaccine in HPV16 Associated Cervical Cancer
NCT02405221 ·Status: COMPLETED ·Phase: PHASE1
-
Quality Improvement Strategies to Increase Human Papillomavirus (HPV) Vaccination
NCT03442062 ·Status: COMPLETED ·Phase: NA
-
The HPV 9-10 Trial: Early Initiation of HPV Vaccination
NCT04722822 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial
NCT07104240 ·Status: RECRUITING ·Phase: NA
-
Dose-Ranging Study of Quadrivalent Human Papillomavirus (HPV) (Types 6,11,16,18) L1 Virus-Like Particle (VLP) Vaccine (V501-007)(COMPLETED)
NCT00365716 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL
NCT02576561 ·Status: UNKNOWN ·Phase: PHASE2
-
Increasing Optimal Use of HPV Vaccination in Primary Care
NCT04180462 ·Status: COMPLETED ·Phase: NA
-
HPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved Adults
NCT04474821 ·Status: COMPLETED ·Phase: PHASE4
-
Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants
NCT00128661 ·Status: COMPLETED ·Phase: PHASE3
-
Human Papilloma Viruses (HPV) Vaccine Adherence Community Clinic Study
NCT01908517 ·Status: COMPLETED ·Phase: NA
-
Patient Decision Aid Tool for HPV Vaccination Among Adults Ages 27-45 Years Old
NCT06435338 ·Status: COMPLETED ·Phase: NA
-
Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination
NCT02537756 ·Status: COMPLETED ·Phase: NA
-
AFIX to Improve HPV Vaccination
NCT02370459 ·Status: COMPLETED ·Phase: NA